1. Home
  2. MRVI vs BLZE Comparison

MRVI vs BLZE Comparison

Compare MRVI & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • BLZE
  • Stock Information
  • Founded
  • MRVI 2014
  • BLZE 2007
  • Country
  • MRVI United States
  • BLZE United States
  • Employees
  • MRVI 560
  • BLZE N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • BLZE Computer Software: Prepackaged Software
  • Sector
  • MRVI Health Care
  • BLZE Technology
  • Exchange
  • MRVI Nasdaq
  • BLZE Nasdaq
  • Market Cap
  • MRVI 350.1M
  • BLZE 300.7M
  • IPO Year
  • MRVI 2020
  • BLZE 2021
  • Fundamental
  • Price
  • MRVI $2.42
  • BLZE $8.35
  • Analyst Decision
  • MRVI Hold
  • BLZE Strong Buy
  • Analyst Count
  • MRVI 10
  • BLZE 7
  • Target Price
  • MRVI $5.84
  • BLZE $10.21
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • BLZE 755.2K
  • Earning Date
  • MRVI 08-11-2025
  • BLZE 08-07-2025
  • Dividend Yield
  • MRVI N/A
  • BLZE N/A
  • EPS Growth
  • MRVI N/A
  • BLZE N/A
  • EPS
  • MRVI N/A
  • BLZE N/A
  • Revenue
  • MRVI $219,830,000.00
  • BLZE $137,286,000.00
  • Revenue This Year
  • MRVI N/A
  • BLZE $16.78
  • Revenue Next Year
  • MRVI $7.23
  • BLZE $13.98
  • P/E Ratio
  • MRVI N/A
  • BLZE N/A
  • Revenue Growth
  • MRVI N/A
  • BLZE 19.08
  • 52 Week Low
  • MRVI $1.67
  • BLZE $3.94
  • 52 Week High
  • MRVI $9.60
  • BLZE $8.65
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • BLZE 75.27
  • Support Level
  • MRVI $2.28
  • BLZE $7.99
  • Resistance Level
  • MRVI $2.47
  • BLZE $8.65
  • Average True Range (ATR)
  • MRVI 0.14
  • BLZE 0.38
  • MACD
  • MRVI -0.01
  • BLZE 0.04
  • Stochastic Oscillator
  • MRVI 27.45
  • BLZE 77.08

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

Share on Social Networks: